ThinkCyte
PrivateLast Round
Grant
Aug 4, 2025
Total Funding Raised
$129.9M
Company Overview
ThinkCyte is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThinkCyte Comparables
Compare ThinkCyte with similar companies based on industry and business-model similarity.
ThinkCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 4, 2025 | ||||
| Series C | Aug 29, 2024 | ||||
| Debt | Aug 29, 2024 | ||||
| Grant | Nov 28, 2023 | ||||
| Series C | Nov 28, 2023 | ||||
Grant | Oct 18, 2023 |
Key People
Founding team and executive leadership
ThinkCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| ITOCHU Technology Ventures | Series C, Series B, Series A |
| Sumitomo Mitsui Trust Bank | Series C |
| 株式会社日本政策金融公庫 | Debt |
| New Energy and Industrial Technology Development Organization | Grant |
| Global Brain Corporation | Series C |
| Japan Investment Adviser | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2025
Added Almog Diagnostic & Medical Equipment Ltd. as a customer.
- Jun 3, 2025
Launched MorphoScan Cloud, a cloud-based platform for AI-driven cell morphology analysis.
ThinkCyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ThinkCyte's valuation, stock price, and market status.